Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination

Details for Australian Patent Application No. 2008215397 (hide)

Owner TOYAMA CHEMICAL CO., LTD.

Inventors Maekawa, Masako

Agent Griffith Hack

Pub. Number AU-B-2008215397

PCT Pub. Number WO2008/099874

Priority 2007-035975 16.02.07 JP

Filing date 14 February 2008

Wipo publication date 21 August 2008

Acceptance publication date 6 September 2012

International Classifications

C07D 241/24 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/215

A61K 31/4965 - Non-condensed pyrazines

A61P 31/16 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/099874 Priority application(s): WO2008/099874

6 September 2012 Application Accepted

  Published as AU-B-2008215397

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008215411-Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy2-methylaminoquinazolin-4-yl)phenyl]te rephthalamic acid

2008215384-Crystalline forms of thiazolidinedione compound and its manufacturing method